Body and Mind Inc. (BAMM.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 30.54 Million USD | 46.03% |
| 2022 | 20.92 Million USD | 51.87% |
| 2021 | 13.77 Million USD | 150.69% |
| 2020 | 5.49 Million USD | 80.57% |
| 2019 | 3.04 Million USD | -35.59% |
| 2018 | 4.72 Million USD | 2341.95% |
| 2017 | 193.48 Thousand USD | -46.24% |
| 2016 | 359.87 Thousand USD | -59.75% |
| 2015 | 894.19 Thousand USD | -0.15% |
| 2014 | 895.57 Thousand USD | 25.11% |
| 2013 | 715.83 Thousand USD | 97.36% |
| 2012 | 362.7 Thousand USD | 115.06% |
| 2011 | 168.65 Thousand USD | 80.05% |
| 2010 | 93.66 Thousand USD | -37.78% |
| 2009 | 150.53 Thousand USD | -27.43% |
| 2008 | 207.42 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 28.11 Million USD | 1.26% |
| 2024 Q2 | 27.76 Million USD | 2.79% |
| 2024 Q1 | 27.01 Million USD | -11.57% |
| 2023 Q1 | 21.88 Million USD | 4.59% |
| 2023 Q3 | 31.03 Million USD | 12.37% |
| 2023 Q4 | 30.54 Million USD | -1.56% |
| 2023 Q2 | 27.61 Million USD | 26.21% |
| 2023 FY | 30.54 Million USD | 46.03% |
| 2022 Q3 | 22.69 Million USD | 7.09% |
| 2022 Q2 | 21.19 Million USD | 45.36% |
| 2022 Q1 | 14.58 Million USD | 5.86% |
| 2022 Q4 | 20.92 Million USD | -7.84% |
| 2022 FY | 20.92 Million USD | 51.87% |
| 2021 Q2 | 8.92 Million USD | 24.14% |
| 2021 FY | 13.77 Million USD | 150.69% |
| 2021 Q1 | 7.19 Million USD | 30.9% |
| 2021 Q3 | 9.41 Million USD | 5.42% |
| 2021 Q4 | 13.77 Million USD | 46.33% |
| 2020 Q1 | 3.99 Million USD | 31.27% |
| 2020 FY | 5.49 Million USD | 80.57% |
| 2020 Q4 | 5.49 Million USD | 10.34% |
| 2020 Q3 | 4.97 Million USD | 21.41% |
| 2020 Q2 | 4.1 Million USD | 2.68% |
| 2019 Q2 | 8.59 Million USD | 75.11% |
| 2019 FY | 3.04 Million USD | -35.59% |
| 2019 Q4 | 3.04 Million USD | -66.71% |
| 2019 Q1 | 4.9 Million USD | 3.91% |
| 2019 Q3 | 9.14 Million USD | 6.33% |
| 2018 Q4 | 4.72 Million USD | 77.79% |
| 2018 Q2 | 2.67 Million USD | 602.83% |
| 2018 FY | 4.72 Million USD | 2341.95% |
| 2018 Q1 | 381 Thousand USD | 96.92% |
| 2018 Q3 | 2.65 Million USD | -0.76% |
| 2017 Q3 | 198.48 Thousand USD | -50.8% |
| 2017 Q2 | 403.42 Thousand USD | 12.68% |
| 2017 Q1 | 358.04 Thousand USD | -0.51% |
| 2017 FY | 193.48 Thousand USD | -46.24% |
| 2017 Q4 | 193.48 Thousand USD | -2.52% |
| 2016 Q1 | 920.61 Thousand USD | 2.96% |
| 2016 FY | 359.87 Thousand USD | -59.75% |
| 2016 Q4 | 359.87 Thousand USD | -64.87% |
| 2016 Q3 | 1.02 Million USD | 14.27% |
| 2016 Q2 | 896.46 Thousand USD | -2.62% |
| 2015 FY | 894.19 Thousand USD | -0.15% |
| 2015 Q4 | 894.19 Thousand USD | -2.62% |
| 2015 Q3 | 918.28 Thousand USD | 7.08% |
| 2015 Q2 | 857.59 Thousand USD | -5.14% |
| 2015 Q1 | 904.05 Thousand USD | 0.95% |
| 2014 Q1 | 738.35 Thousand USD | 3.15% |
| 2014 FY | 895.57 Thousand USD | 25.11% |
| 2014 Q3 | 785.71 Thousand USD | 6.64% |
| 2014 Q4 | 895.57 Thousand USD | 13.98% |
| 2014 Q2 | 736.77 Thousand USD | -0.21% |
| 2013 Q2 | 523.42 Thousand USD | 13.66% |
| 2013 Q4 | 715.83 Thousand USD | 18.86% |
| 2013 Q1 | 460.51 Thousand USD | 26.96% |
| 2013 FY | 715.83 Thousand USD | 97.36% |
| 2013 Q3 | 602.26 Thousand USD | 15.06% |
| 2012 Q2 | 74.04 Thousand USD | -35.73% |
| 2012 Q1 | 115.2 Thousand USD | -31.69% |
| 2012 Q3 | 208.51 Thousand USD | 181.63% |
| 2012 Q4 | 362.7 Thousand USD | 73.95% |
| 2012 FY | 362.7 Thousand USD | 115.06% |
| 2011 Q3 | 103.36 Thousand USD | -50.01% |
| 2011 Q4 | 168.65 Thousand USD | 63.16% |
| 2011 Q2 | 206.79 Thousand USD | 62.78% |
| 2011 Q1 | 127.04 Thousand USD | 35.63% |
| 2011 FY | 168.65 Thousand USD | 80.05% |
| 2010 Q2 | 195.76 Thousand USD | 15.79% |
| 2010 FY | 93.66 Thousand USD | -37.78% |
| 2010 Q1 | 169.06 Thousand USD | 12.31% |
| 2010 Q4 | 93.66 Thousand USD | -65.62% |
| 2010 Q3 | 272.45 Thousand USD | 39.18% |
| 2009 FY | 150.53 Thousand USD | -27.43% |
| 2009 Q2 | 229.24 Thousand USD | 10.56% |
| 2009 Q1 | 207.34 Thousand USD | 0.0% |
| 2009 Q3 | 260.75 Thousand USD | 13.75% |
| 2009 Q4 | 150.53 Thousand USD | -42.27% |
| 2008 FY | 207.42 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -940.334% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | -113.349% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -6389.887% |
| The BC Bud Corporation | 626 Thousand CAD | -4780.063% |
| BioNxt Solutions Inc. | 6.55 Million CAD | -366.387% |
| CordovaCann Corp. | 11.29 Million CAD | -170.566% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | -259.362% |
| Captor Capital Corp. | 28.76 Million CAD | -6.205% |
| City View Green Holdings Inc. | 3.73 Million CAD | -718.366% |
| 1CM Inc. | 9.42 Million CAD | -224.177% |
| Global Hemp Group Inc. | 5.82 Million CAD | -424.44% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | -44.277% |
| IM Cannabis Corp. | 35.11 Million CAD | 12.997% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -1142.038% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | -203.041% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -11740.848% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | -593.775% |
| Ovation Science Inc. | 728.99 Thousand CAD | -4090.634% |
| Pharmadrug Inc. | 2.92 Million CAD | -944.256% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -1362.424% |
| RAMM Pharma Corp. | 2.83 Million CAD | -977.386% |
| RIV Capital Inc. | 275.63 Million CAD | 88.917% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | -797.473% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 91.622% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 18.714% |
| 1933 Industries Inc. | 23.28 Million CAD | -31.21% |
| Red Light Holland Corp. | 3.82 Million CAD | -699.375% |
| Top Strike Resources Corp. | 20.99 Million CAD | -45.515% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -3767.232% |
| Adastra Holdings Ltd. | 17.65 Million CAD | -73.01% |